267 related articles for article (PubMed ID: 19171200)
1. The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes.
Pavez Loriè E; Li H; Vahlquist A; Törmä H
Biochim Biophys Acta; 2009 Mar; 1791(3):220-8. PubMed ID: 19171200
[TBL] [Abstract][Full Text] [Related]
2. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Pavez Loriè E; Chamcheu JC; Vahlquist A; Törmä H
Arch Dermatol Res; 2009 Aug; 301(7):475-85. PubMed ID: 19294396
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
[TBL] [Abstract][Full Text] [Related]
4. CYP26B1 plays a major role in the regulation of all-trans-retinoic acid metabolism and signaling in human aortic smooth muscle cells.
Ocaya PA; Elmabsout AA; Olofsson PS; Törmä H; Gidlöf AC; Sirsjö A
J Vasc Res; 2011; 48(1):23-30. PubMed ID: 20606468
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.
Zolfaghari R; Cifelli CJ; Lieu SO; Chen Q; Li NQ; Ross AC
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1029-36. PubMed ID: 17185629
[TBL] [Abstract][Full Text] [Related]
6. The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes.
Giltaire S; Herphelin F; Frankart A; Hérin M; Stoppie P; Poumay Y
Br J Dermatol; 2009 Mar; 160(3):505-13. PubMed ID: 19120344
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid.
Tang XH; Vivero M; Gudas LJ
Exp Cell Res; 2008 Jan; 314(1):38-51. PubMed ID: 17727842
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450s in the regulation of cellular retinoic acid metabolism.
Ross AC; Zolfaghari R
Annu Rev Nutr; 2011 Aug; 31():65-87. PubMed ID: 21529158
[TBL] [Abstract][Full Text] [Related]
9. The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo.
Reijntjes S; Blentic A; Gale E; Maden M
Dev Biol; 2005 Sep; 285(1):224-37. PubMed ID: 16054125
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the
Stevison F; Hogarth C; Tripathy S; Kent T; Isoherranen N
Drug Metab Dispos; 2017 Jul; 45(7):846-854. PubMed ID: 28446509
[No Abstract] [Full Text] [Related]
11. Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells.
Helvig C; Taimi M; Cameron D; Jones G; Petkovich M
J Pharmacol Toxicol Methods; 2011; 64(3):258-63. PubMed ID: 21906690
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible.
Popa C; Dicker AJ; Dahler AL; Saunders NA
Br J Dermatol; 1999 Sep; 141(3):460-8. PubMed ID: 10583049
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases.
Topletz AR; Thatcher JE; Zelter A; Lutz JD; Tay S; Nelson WL; Isoherranen N
Biochem Pharmacol; 2012 Jan; 83(1):149-63. PubMed ID: 22020119
[TBL] [Abstract][Full Text] [Related]
14. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
15. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models.
Heise R; Mey J; Neis MM; Marquardt Y; Joussen S; Ott H; Wiederholt T; Kurschat P; Megahed M; Bickers DR; Merk HF; Baron JM
J Invest Dermatol; 2006 Nov; 126(11):2473-80. PubMed ID: 16778795
[TBL] [Abstract][Full Text] [Related]
16. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents.
Stoppie P; Borgers M; Borghgraef P; Dillen L; Goossens J; Sanz G; Szel H; Van Hove C; Van Nyen G; Nobels G; Vanden Bossche H; Venet M; Willemsens G; Van Wauwe J
J Pharmacol Exp Ther; 2000 Apr; 293(1):304-12. PubMed ID: 10734183
[TBL] [Abstract][Full Text] [Related]
17. Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick.
Roberts C; Ivins S; Cook AC; Baldini A; Scambler PJ
Hum Mol Genet; 2006 Dec; 15(23):3394-410. PubMed ID: 17047027
[TBL] [Abstract][Full Text] [Related]
18. Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism.
Ross AC; Cifelli CJ; Zolfaghari R; Li NQ
Physiol Genomics; 2011 Jan; 43(1):57-67. PubMed ID: 21045116
[TBL] [Abstract][Full Text] [Related]
19. Expression of the retinoic acid catabolic enzyme CYP26B1 in the human brain to maintain signaling homeostasis.
Stoney PN; Fragoso YD; Saeed RB; Ashton A; Goodman T; Simons C; Gomaa MS; Sementilli A; Sementilli L; Ross AW; Morgan PJ; McCaffery PJ
Brain Struct Funct; 2016 Jul; 221(6):3315-26. PubMed ID: 26374207
[TBL] [Abstract][Full Text] [Related]
20. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid.
Taimi M; Helvig C; Wisniewski J; Ramshaw H; White J; Amad M; Korczak B; Petkovich M
J Biol Chem; 2004 Jan; 279(1):77-85. PubMed ID: 14532297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
